Vol. 56 No. 9 (2017): Acta Oncologica

Articles

• The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer

  K. Bujko, L. Pietrzak, M. Partycki, M. Szczepkowski, L. Wyrwicz, M. Rupiński, A. Rutkowsk, A. Mróz

  1152-1154

  Published: 2017-09-02

  • PDF

• Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy

  Dario Di Perri, John A. Lee, Anne Bol, François-Xavier Hanin, Guillaume Janssens, Daniel Labar, Annie Robert, Edmond Sterpin, Xavier Geets

  1181-1188

  Published: 2017-09-02

  • PDF

• Adverse events in hospitalised cancer patients: a comparison to a general hospital population

  Ellinor Christin Haukland, Christian von Plessen, Carsten Nieder, Barthold Vonen

  1218-1223

  Published: 2017-09-02

  • PDF

• Radiation physiology – evidence for a higher biological effect of 24 Gy in four fractions as compared to three

  Gunnar Steineck, Cecilia Bull, Marie Kalm, Fei Sjöberg, Eleftheria Alevronta, Dilip Kumar Malipatlolla, Karin Bergmark, Bengt Jeppsson, Ulrica Wilderäng, Thomas Björk-Eriksson

  1240-1243

  Published: 2017-09-02

  • PDF

• What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?

  B. Glimelius, A. Martling

  1139-1142

  Published: 2017-09-02

  • PDF

• The will to live – breast cancer patients perceptions’ of palliative chemotherapy

  Jenny Bergqvist, Peter Strang

  1168-1174

  Published: 2017-09-02

  • PDF

• Admittance to specialized palliative care (SPC) of patients with an assessed need: a study from the Danish palliative care database (DPD)

  Mathilde Adsersen, Lau Caspar Thygesen, Mette Asbjoern Neergaard, Anders Bonde Jensen, Per Sjøgren, Anette Damkier, Mogens Groenvold

  1210-1217

  Published: 2017-09-02

  • PDF

• Combined modality therapy improves overall survival for angiosarcoma

  Colette J. Shen, Aaron S. Parzuchowski, Megan N. Kummerlowe, Carol D. Morris, Christian F. Meyer, Mehran Habibi, Deborah A. Frassica, Adam S. Levin, Katherine A. Thornton, Stephanie A. Terezakis

  1235-1238

  Published: 2017-09-02

  • PDF

• Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study

  Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Thomas P. Ahern, Marco Mele, Marianne Ewertz, Stephen Hamilton-Dutoit, Peer M. Christiansen, Bent Ejlertsen, Henrik T. Sørensen, Timothy L. Lash, Rebecca A. Silliman

  1155-1160

  Published: 2017-09-02

  • PDF

• Parotid gland mean dose as a xerostomia predictor in low-dose domains

  Hubert Szymon Gabryś, Florian Buettner, Florian Sterzing, Henrik Hauswald, Mark Bangert

  1197-1203

  Published: 2017-09-02

  • PDF

• Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma

  George Papaxoinis, Jamie M. J. Weaver, Leila Khoja, Ana Patrao, Sofia Stamatopoulou, Alia Alchawaf, Vikki Owen-Holt, Theodora Germetaki, Zoe Kordatou, Wasat Mansoor

  1224-1232

  Published: 2017-09-02

  • PDF

• Mid-treatment magnetic resonance imaging in pediatric intracranial low-grade gliomas treated with proton beam therapy

  Radhika Sreeraman Kumar, Ronny L. Rotondo, Julie A. Bradley, Tamara Vern-Gross, Soonki Huh, Daniel J. Indelicato

  1243-1247

  Published: 2017-09-02

  • PDF

• Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

  Alexios Matikas, Theodoros Foukakis, Jonas Bergh

  1143-1151

  Published: 2017-09-02

  • PDF

• Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study

  Fred Hsu, Alan Nichol, Ted Toriumi, Alex De Caluwe

  1175-1180

  Published: 2017-09-02

  • PDF

• Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014

  Kirstine Kim Schmidt Karnov, Christian Grønhøj, David Hebbelstrup Jensen, Irene Wessel, Birgitte Wittenborg Charabi, Lena Specht, Andreas Kjaer, Christian von Buchwald

  1204-1209

  Published: 2017-09-02

  • PDF

• Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal

  Floor J. E. Lubberman, Nielka P. van Erp, Rob ter Heine, Carla M. L. van Herpen

  1238-1240

  Published: 2017-09-02

  • PDF

• A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

  Katrine L. H. Weischenfeldt, Tove Kirkegaard, Birgitte B. Rasmussen, Anita Giobbie-Hurder, Maj-Britt Jensen, Bent Ejlertsen, Anne E. Lykkesfeldt

  1161-1167

  Published: 2017-09-02

  • PDF

• Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions

  Kristin Karlsson, Ingmar Lax, Elias Lindbäck, Gavin Poludniowski

  1189-1196

  Published: 2017-09-02

• Fatal heart failure in a young adult female sarcoma patient treated with pazopanib

  Vicky L. M. N. Soomers, Ingrid M. E. Desar, Nielka P. van Erp, Jeroen Verwiel, Suzanne E. J. Kaal, Winette T. A. van der Graaf

  1233-1234

  Published: 2017-09-02

  • PDF